RhoVac

RhoVac

RhoVac is an immuno-oncology company developing a novel therapeutic cancer vaccine that targets metastatic cancer cells. Overexpression of RhoC protein is a characteristic of most type of metastati...

RhoVac's Basic Information

Headquarters
Sweden
Founded Year
2008
Headcount
11 - 50
Specialties
Immuno-oncologyCancer vaccinesMetastatic cancer cells

RhoVac's Competitors

Pathcom systems
Pathcom systems

Maniyar Seeds Pvt. Ltd.
Maniyar Seeds Pvt. Ltd.

DART Diagnostics
DART Diagnostics

Proimi - CONICET
Proimi - CONICET

Bahrain

Allied Chemical Technologies
Allied Chemical Technologies

Employee Insights

Employee Function

Employee Location

RhoVac's Top Employees

people
Steffen Jørgensen
Chief Development Officer
people
Anders Ljungqvist
Chief Operations Officer AT Rhovac
people
Anders Månsson
Chief Executive Officer

Find Your Next Customer with Better Data

Get access to over 160 million contacts and companies' information in AroundDeal's B2B database, quickly build highly targeted prospect lists and directly reach the buying committee.

Top-ranked on G2 Crowd
🛡️GDPR compliantCancel anytime
Free credits every month!

Frequently Asked Questions Regarding RhoVac

Where is RhoVac's headquarter located?

RhoVac's headquarter are located at Sweden.

How many employees does RhoVac have?

RhoVac has 11 - 50 employees.

What is RhoVac's official website?

RhoVac's official website is http://rhovac.com

What does RhoVac do?

RhoVac is an immuno-oncology company developing a novel therapeutic cancer vaccine that targets metastatic cancer cells. Overexpression of RhoC protein is a characteristic of most type of metastati...

What specialty does RhoVac have?

Immuno-oncologyCancer vaccinesMetastatic cancer cells

Connect with anyone with AroundDeal today!

Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
cta